-
www.ahrq.gov/research/findings/nhqrdr/2014chartbooks/hispanichealth/part3.html
March 01, 2020 - most effective prevention and treatment practices for the leading causes of mortality, starting with cardiovascular
-
www.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
December 01, 2017 - Development and pilot evaluation of a preoperative briefing protocol for cardiovascular surgery.
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2014_MaskedStats_Dx_Pr_Grps.PDF
January 01, 2014 - pharynx 24,366 0.34%
06: Operations on the respiratory system 123,503 1.75%
07: Operations on the cardiovascular
-
effectivehealthcare.ahrq.gov/sites/default/files/renal-cancer_disposition-comments.pdf
February 24, 2016 - cT2 renal cancer patients which
may impact clinical decision making—such as
a) metabolic sequelae/cardiovascular … Renal Functional Outcomes: Should also be broadened to include
cardiovascular and metabolic endpoints … Cardiovascular and metabolic endpoints
specifically were not part of the KQ in this report. … There is an emerging literature regarding the
cardiovascular sequelae of renal interventions,
Source … suggest an impact long-term from renal surgery, on cardiovascular and
metabolic sequelae, with a potential
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/2Wc3FRHpVDPX2jT_WzjEXX
July 31, 2020 - The USPSTF has made a recommendation statement on aspirin use to prevent cardiovascular disease and colorectal … Recommendations
The USPSTF has a recommendation statement on aspirin use
for the primary prevention of cardiovascular … sure for the burden of screening), and resulting harms from colo-
noscopy (ie, gastrointestinal and cardiovascular … and frequency
Stool tests
Harms: Estimated lifetime number of complications (gastrointestinal and cardiovascular … Aspirin use for the primary prevention
of cardiovascular disease and colorectal cancer: U.S.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/impaired-visual-acuity-in-older-adults-screening-2016
March 01, 2016 - significantly decreased risk of all-cause mortality (22% vs 25%; adjusted HR, 0.83; 95% CI, 0.73–0.95) and cardiovascular … lung cancer in smokers
(beta-carotene 59 , 60 ) when prescribed for prevention of cancer or
cardiovascular … Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled … Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. … AREDS, Age-Related Eye Disease Study; aRR, adjusted risk ratio; BCVA, best-corrected visual acuity; CV, cardiovascular
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions
January 19, 2021 - Varenicline and adverse cardiovascular events: a systematic review and meta-analysis of randomized controlled … Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis. … 15 reviews
NRT, bupropion, and varenicline were not associated with an increased risk in major cardiovascular … or neuropsychiatric adverse events
NRT was associated with a higher rate of any cardiovascular adverse … precise
Many trials that report cessation effectiveness do not report adverse events, particularly cardiovascular
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-pain-opioid-treatment_executive.pdf
September 19, 2014 - escalation versus maintenance of doses in patients
on long-term opioid therapy, additional outcomes (e.g.,
cardiovascular … gastrointestinal-related
harms, falls, fractures, motor vehicle accidents,
endocrinological harms, infections, cardiovascular … which we used to
identify potentially relevant studies, went through October
2008.29 For outcomes (cardiovascular … gastrointestinal harms, fractures, falls, motor
vehicle accidents, endocrinological harms, infections,
cardiovascular … Other studies have begun to characterize cardiovascular,
endocrinological, and injury-related harms
-
www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/surgery/4-overview-facilitator-guide.docx
January 01, 2019 - The preoperative interventions resulted in decreased complications (wound, cardiovascular, and reoperation
-
psnet.ahrq.gov/web-mm/toxic-tachycardia
March 01, 2005 - The pulmonary, cardiovascular, skin, and neurologic examinations were all unremarkable.
-
psnet.ahrq.gov/web-mm/xl-or-smaller
September 13, 2017 - Another reason is that cardiovascular drugs, hormonal replacement therapy, and psychiatric drugs, which
-
www.ahrq.gov/hai/tools/mvp/modules/technical/daily-care-processes-slides.html
January 01, 2017 - Cardiovascular and interventional laboratory.
7. During a code on the floor.
8.
-
www.ahrq.gov/sites/default/files/wysiwyg/takeheart/training/module-5-slides.pdf
December 31, 2022 - for Mass General
Brigham Healthcare
(EPIC EMR)
Kathy Lee Bishop, PT, DPT, CCS, FNAP
Board-Certified Cardiovascular
-
www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/heart-health/smoking-use-ready-or-not.pdf
June 02, 2025 - reminder for this project that at least
one-out-of-three deaths caused by smoking are related to the cardiovascular
-
psnet.ahrq.gov/node/49683/psn-pdf
April 01, 2013 - requires careful metabolic monitoring, as patients with severe mental illness have elevated risks of
cardiovascular
-
psnet.ahrq.gov/web-mm/timely-diagnosis-esophageal-perforation
September 27, 2023 - Operative Techniques in Thoracic and Cardiovascular Surgery . 2008;13:126-137.
-
psnet.ahrq.gov/web-mm/rapid-mis-strep
February 01, 2004 - Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease
-
www.ahrq.gov/research/findings/nhqrdr/chartbooks/blackhealth/part3-nqs3.html
June 01, 2018 - of the Heckler Report—Care for Cancer
Part 2: Trends in Priorities of the Heckler Report—Care for Cardiovascular
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2004_SummaryStats_10PCT_SEVERITY_A.PDF
January 01, 2004 - AMI, HEART FAILURE OR SHOCK 3002 0.38
173: OTHER VASCULAR PROCEDURES 4491 0.56
174: PERCUTANEOUS CARDIOVASCULAR … PROCEDURES W AMI 4992 0.62
175: PERCUTANEOUS CARDIOVASCULAR PROCEDURES W/O AMI 11643 1.45
176: CARDIAC … PROCS W/O CC 563 0.07
1101: MAJOR CARDIOVASCULAR PROCS W CC 1252 0.16
1102: MAJOR CARDIOVASCULAR PROCS … System 21 0.00
CVS81: Neoplasm, Malignant, Cardiovascular <= 10 **.**
CVS82: Other Atherosclerosis … 1126 0.14
CVS83: Other Cardiac Conditions 419 0.05
CVS84: Other Cardiovascular Symptoms 411 0.05
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2003_SummaryStats_10PCT_SEVERITY_B.PDF
January 01, 2003 - AMI, HEART FAILURE OR SHOCK 2805 0.35
173: OTHER VASCULAR PROCEDURES 3739 0.47
174: PERCUTANEOUS CARDIOVASCULAR … PROCEDURES W AMI 4762 0.60
175: PERCUTANEOUS CARDIOVASCULAR PROCEDURES W/O AMI 11191 1.40
176: CARDIAC … PROCS W/O CC 519 0.07
1101: MAJOR CARDIOVASCULAR PROCS W CC 1086 0.14
1102: MAJOR CARDIOVASCULAR PROCS … System 21 0.00
CVS81: Neoplasm, Malignant, Cardiovascular <= 10 **.**
CVS82: Other Atherosclerosis … 1083 0.14
CVS83: Other Cardiac Conditions 403 0.05
CVS84: Other Cardiovascular Symptoms 448 0.06